Advertisement

Metabolic Brain Disease

, Volume 32, Issue 2, pp 471–481 | Cite as

Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington’s disease model in rats

  • Sarumani Natarajan Suganya
  • Thangarajan SumathiEmail author
Original Article

Abstract

Dietary compounds like flavonoids may offer protection against neurodegeneration. Huntington’s disease (HD) is a neurodegenerative disorder characterized by symptoms like chorea and dementia. 3-Nitropropionic acid (3-NP), a Succinate dehydrogenase (SDH) inhibitor produces behavioral, biochemical and histological changes in the striatum, mimics HD in animals and humans. The present study was designed to examine the protective activity of Rutin (RT), a primary flavonoid from citrus fruits, green tea on 3-NP induced experimental model of HD in rats. Rats were pretreated with Rutin, a potent antioxidant (25 and 50 mg/kg b.w.) orally prior to the intraperitoneally (i.p.) administration of 3-NP (10 mg/kg b.w.) for 14 days. Behavioral assessments were carried out on 5th, 10th and 15th day after 3-NP treatment. Body weight, biochemical and histological studies were analyzed on 15th day. Systemic administration of 3-NP significantly reduced the body weight, locomotor activities (Rota rod, Open field test), memory (Morris water maze) and antioxidants such as Glutathione (GSH) levels, activities of Superoxide dismutase (SOD), Catalase (CAT), Glutathione peroxidase (GPx), Glutathione-S-transferase (GST), Glutathione reductase (GR). 3-NP also produces striatal damage by increased the levels of lipid peroxides, nitrite, Glial Fibrillary Acidic Protein (GFAP) and activity of Acetylcholine esterase (AchE). Thus, Rutin treatment of 25 and 50 mg/kg b.w. has significantly restored all the biochemical, behavioral and histological alterations caused by the 3-NP through its antioxidant activity. The findings of our study indicates that Rutin may have an important role in protecting the striatum from oxidative/nitrosative insults caused by 3-NP. These results suggest that RT might be a drug of choice to treat HD.

Keywords

3-nitropropionic acid Rutin Antioxidants Neurobehavior GFAP 

Notes

Acknowledgments

The financial support extended by UGC in the form of project fellow under UGC- BSR Research fellowship in science is gratefully acknowledged.

Compliance with ethical standards

Conflict of interest

The authors declare that there is no conflict of interests.

References

  1. Abd-El-Fattah AA, El-Sawalhi MM et al (2010) Possible role of vitamin E, coenzyme Q10 and rutin protection against cerebral ischemia/reperfusion injury in irradiated rats. Int J Radiat Biol 86:1070–1078CrossRefPubMedGoogle Scholar
  2. Ahuja M, Bishnoi M, Chopra K (2008) Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity.Toxicology 244, 2–3, 28;111–122Google Scholar
  3. Aleksandrov PN, Speranskaia TV, BobkovIu G, et al. (1986) Effect of Rutin and esculamine on models of aseptic inflammation. FarmakolToksiko l49:84–86.Google Scholar
  4. Alexi T, Hughes PE, Faull RLM, Williams CE (1998) 3-nitropropionic acid’s lethal triplet: cooperative pathways of neurodegeneration. Neuroreport 9:57–64CrossRefGoogle Scholar
  5. Bains JS, Shaw CA (1997) Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death. Brain Res Rev 25:335–358CrossRefPubMedGoogle Scholar
  6. Beal M.F., Brouillet, E., Jenkins, B.G., Ferrante, R.J., Kowall, N.W., Miller, J.M., Storey, E., Srivastava, R., Rosen, B.R., Hyman, B.T (1993) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J. Neurosci 13:4181–4192Google Scholar
  7. Bishnoi M, Chopra K, Kulkarni SK (2007) Protective effect of rutin, a polyphenolic flavonoid against haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes. Fundam Clin Pharmacol 21(5):521–9Google Scholar
  8. Bonsi P, Cuomo D, Martella G, Sciamanna G, Tolu M, Calabresi P (2006) Mitochondrial toxins in basal ganglia disorders: from animal models to therapeutic strategies. Current Neuropharm 4:69–75CrossRefGoogle Scholar
  9. Brouillet E, Jenkins BG, Hyman BT, Ferrante RJ et al (1993) Age-dependant vulnerability of the striatum to the mitochondrial toxin 3- nitropropionic acid. J Neurochem 60:356–359CrossRefPubMedGoogle Scholar
  10. Browne SE, Ferrante RJ, Beal MF (1999) Oxidative stress in Huntington’s disease. Brain Pathol 9:147–163CrossRefPubMedGoogle Scholar
  11. Chen S, Gong J, Liu F, Mohammed U (2000) Naturally occurring polyphenolic antioxidants modulate IgE-mediated mast cell activation. Immunology 100:471–480CrossRefPubMedPubMedCentralGoogle Scholar
  12. Chopra K, Kulkarni SK (2007) Protective effect of rutin, a polyphenolic flavonoid against haloperidol-induced orofacial dyskinesia and associated behavioral, biochemical and neurochemical changes. Fundam Clin Pharmacol 21:521–529CrossRefPubMedGoogle Scholar
  13. Cole CJ, Edmondson DE, Singer TP (1979) Inactivation of succinate dehydrogenase by 3-nitropropionic acid. J BiolChem 254:5161–5167Google Scholar
  14. Cote SL, Ribeiro-Da-Silva A, Cuello AC (1993) Immunocytochemistry II. John Wiley and Sons, New YorkGoogle Scholar
  15. Cruz T, Galvez J, Ocete MA, Crespo ME et al (1998) Oral administration of rutoside can ameliorate inflammatory bowel disease in rats. Life Sci 62:687–695CrossRefPubMedGoogle Scholar
  16. Deshpande SB, Hida H, Takei-Io N, Masuda T, Baba H, Nishino H (2006) Involvement of nitric oxide in 3-nitropropionic acid-induced striatal toxicity in rats. Brain Res 1108:205–215Google Scholar
  17. Ellman GL, Courtney KD, Andres V, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. BiochemPharmacol 7:88–89Google Scholar
  18. Fernandez SP, Wasowski C, Loscalzo LM (2006) Central nervous system depressant action of flavonoid glycosides. Eur J Pharmacol 539:168–176CrossRefPubMedGoogle Scholar
  19. Frautschy SA, Hu W, Kim P, Miller SA. Chu T, et al. (2001) Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology. Neurobiol Aging 22: 993–1005.Google Scholar
  20. Fu YT, He FS, Zhang SL, Zhang JS (1995) Lipid peroxidation in rats intoxicated with 3-nitropropionic acid. Toxicon 33:327–331CrossRefPubMedGoogle Scholar
  21. Green LC, Wagner DA, Glogowski J, Skipper PL et al (1982) Analysis of nitrate, nitrite, and [15 N] nitrate in biological fluids. Anal Biochem 126:131–138CrossRefPubMedGoogle Scholar
  22. Gupta R, Sinha M, Sharma A (2003) Neuroprotective effect of antioxidants on ischaemia and reperfusion- induced cerebral injury. Pharmacol Res 48:209–215CrossRefPubMedGoogle Scholar
  23. Habig WH, Pabst MJ, Jakoby WS (1974) Glutathione -S-transferase: the first enzymatic step in mercapturic acid formation. J BiolChem 249:7130–7139Google Scholar
  24. Hinton SC, Paulsen JS, Hoffmann RG, Reynolds NC et al (2007) Motor timing variability increases in preclinical Huntington’s disease patients as estimated onset of motor symptoms approaches. J Int NeuropsycholSoc 13:539–543Google Scholar
  25. Kamalakkannan N, StanelyMainzen P (2006) Rutin improves the antioxidant status in streptozotocin-induced diabetic rat tissues. Mol Cell Biochem 293:211–219CrossRefPubMedGoogle Scholar
  26. Kasparova S et al (2006) Effect of coenzyme Q10 and vitamin E on brain energy metabolism in the animal model of Huntington’s disease. NeurochemInt 48:93–99CrossRefGoogle Scholar
  27. Katsube T et al (2006) Antioxidant flavonol glycosides in mulberry (Morus alba L.] leaves isolated based on LDL antioxidant activity. Food Chem 97(1):25–31CrossRefGoogle Scholar
  28. Khan MB et al (2006) Prevention of cognitive impairments and neurodegeneration by KhamiraAbresham hakim ArshadWala. J Ethnopharmacol 108:68–73CrossRefPubMedGoogle Scholar
  29. Khan MM et al (2009) Rutin protects the neural damage induced by transient focal ischemia in rats. Brain Res 1292:123–135CrossRefPubMedGoogle Scholar
  30. Kim H, Kong H, Choi B, Yang Y, Kim Y, Lim MJ (2005) Metabolic and pharmacological properties of rutin, a dietary quercetin glycoside, for the treatment of inflammatory bowel disease. Pharm Res 22:1499–1509CrossRefPubMedGoogle Scholar
  31. Koda T, Kuroda Y, Imaia H (2008) Protective effect of rutin against spatial memory impairment induced by trimethyltin in rats. Nutr Res 28:629–634CrossRefPubMedGoogle Scholar
  32. Koda T, Kuroda Y, Imaia H (2009) Rutin supplementation in the diet has protective effects against toxicant-induced hippocampal injury by suppression of microglial activation and pro-inflammatory cytokines. Cell Mol Neurobiol 29(4):523–531CrossRefPubMedGoogle Scholar
  33. Koutouzis TK et al (1994) Systemic 3- nitropropionic acid: long-term effects on locomotor behavior. Brain Res 646:242–246CrossRefPubMedGoogle Scholar
  34. Kumar P, Kumar A (2009a) Protective role of sertraline against 3-nitropropionic acid-induce cognitive dysfunction and redox ratio in striatum, cortex and hippocampus of rat brain. Indian j ExpBiol 47:715–722Google Scholar
  35. Kumar P, Kumar A (2009b) Neuroprotective effect of cyclosporine and FK506 against 3-nitropropionic acid induced cognitive dysfunction and glutathione redox in rat: possible role of nitric oxide. Neurosci Res 63:302–314CrossRefPubMedGoogle Scholar
  36. Kumar P, Kalonia H, Kumar A (2011) Role of LOX/COX pathways in 3-nitropropionic acid-induced Huntington's Disease-like symptoms in rats: protective effect of licofelone. Br J Pharmacol 164:644–654Google Scholar
  37. La Casa C et al (2007) Evidence for protective and antioxidant properties of rutin, a natural flavone, against ethanol-induced gastric lesions. Journal of Ethnopharm 1:45–53Google Scholar
  38. Lafon-Cazal M, Pietri S, Culcasi M, Bockaert J (1993) NMDA-dependent superoxide production and neurotoxicity. Nature 364:535–537CrossRefPubMedGoogle Scholar
  39. Lee WT, Chang C (2004) Magnetic resonance imaging and spectroscopy in assessing 3- nitro propionic acid-induced brain lesions: an animal model of Huntington’s disease. Prog Neurobiol 72:87–110CrossRefPubMedGoogle Scholar
  40. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J BiolChem 193:265–275Google Scholar
  41. Ludolph AC, He F, Spencer PS, Hammerstad J, Sabri M (1991) 3-nitropropionic acid exogenous animal neurotoxin and possible human striatal toxin. Can J NeurolSci 18:492–498CrossRefGoogle Scholar
  42. Manuj A, Bishnoi M, Chopra K (2008) Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity. Toxicol 244:111–122CrossRefGoogle Scholar
  43. Marklund S &Marklund G (1974) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47:469–474Google Scholar
  44. Moron M, Depierre JW, Mannervik BT (1979) Levels of glutathione, glutathione reductase and glutathione-S-transferase activities in rat lung and liver. Biochim Biophys Acta 582:67–78CrossRefPubMedGoogle Scholar
  45. Nassiri-Asl M, Shariati-Rad S, Zamansoltani F (2008) Anticonvulsive effects of intracerebroventricular administration of rutin in rats. ProgNeuro-Psychopharm Biol Psych 32:989–993CrossRefGoogle Scholar
  46. Nassiri-Asl M, Mortazavi SR, Samiee-Rad F, Zangivand AA, Safdari F, Saroukhani S (2010) The effects of rutin on the development of pentylenetetrazole kindling and memory retrieval in rats. Epilepsy Behav 18:50–53Google Scholar
  47. Nowak G et al (2003) Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats. Brain Res Bull 611:59–64Google Scholar
  48. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reactions. Anal Biochem 95:351–358CrossRefPubMedGoogle Scholar
  49. Palfi S, Ferrante RJ, Brouillet E, Beal MF, Dolan R, Guyot MC (1996) Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington’s disease. J Neurosci 16:3019–3025PubMedGoogle Scholar
  50. Pu F, Mishima K, Irie K, Egashira N, Ishibashi D, Matsumoto Y (2005) Differential effects of buckwheat and kudingcha extract on neuronal damage in cultured hippocampal neurons and spatial memory impairment induced by scopolamine in an eight-arm radial maze. J Health Sci 51:636–644CrossRefGoogle Scholar
  51. Pubill D et al (2001) Orphenadrine prevents 3-nitropropionic acid-induced neurotoxicity in vitro and in vivo. Br J Pharmacol 132(3):693–702CrossRefPubMedPubMedCentralGoogle Scholar
  52. Rotruck JT, Popa AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstar WG (1973) Selenium: biochemical role as a component of GPx. Science 179:588–590CrossRefPubMedGoogle Scholar
  53. Ryu JK, Nagai A, Kim J, Lee MC, McLarnon JG, Kim SU (2003) Microglial activation and cell death induced by the mitochondrial toxin 3-nitropropionic acid: in vitro and in vivo studies. Neurobiol Dis 12:121–132CrossRefPubMedGoogle Scholar
  54. Saydoff JA, Liu LS, Garcia RA, Hu Z, Li D, von Borstel RW (2003) Oral uridine pro-drug PN401 decreases neurodegeneration, behavioral impairment, weight loss and mortality in the 3-nitropropionic acid mitochondrial toxin model of Huntington’s disease. Brain Res 994:44–54CrossRefPubMedGoogle Scholar
  55. Schmatz R, Mazzanti CM, Spanevello R, Stefanello N, Gutierres J, Corrêa M et al (2009) Resveratrol prevents memory deficits and the increase in acetylcholinesterase activity in streptozotocin– induced diabetic rats. Eur J Pharmacol 610:42–48CrossRefPubMedGoogle Scholar
  56. Selkoe DJ, Salazar FJ, Abraham C, Kosik KS (1982) Huntington’s disease: changes in striatal proteins reflect astrocytic gliosis. Brain Res 245:117–125CrossRefPubMedGoogle Scholar
  57. Sinha AK (1972) Colorimetric assay of catalase. Anal Biochem 47:389–394CrossRefPubMedGoogle Scholar
  58. Solomon A et al (2010) Antioxidant activities and anthocyanin content of fresh fruits of common fig (Ficuscarica L.]. Agric. Food Chem 58:6660CrossRefGoogle Scholar
  59. Staal GEJ, Visser J, Veeger C (1969) Purification and properties of glutathione reductase of human erythrocytes. Biochim Biophys Act 185:39–48CrossRefGoogle Scholar
  60. Suganya SN, Sumathi T (2014) Rutin attenuates 3-nitropropionic acid induced behavioural alterations and mitochondrial dysfunction in the striatum of rat brain. World journal of pharmacy and pharmaceutical sciences 4:1080–1092Google Scholar
  61. Tabrizi SJ, Workman J, Hart PE, Mangiarini L, Mahal A et al (2000) Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse. Ann Neurol 47:80–86CrossRefPubMedGoogle Scholar
  62. Teunissen CE, Steinbusch HW, Angevaren M, Appels M, de Bruijn C, Prickaerts J, de Vente J (2001) Behavioural correlates of striatal glial fibrillary acidic protein in the 3-nitropropionic acid rat model: disturbed walking pattern and spatial orientation. Neurosci 105:153–167CrossRefGoogle Scholar
  63. Trumbeckaite S et al (2006) The effect of flavonoids on rat heart mitochondrial function. Biomed Pharmacother 60:245–248CrossRefPubMedGoogle Scholar
  64. Vis JC et al (1999) 3-nitropropionic acid induces a spectrum of Huntington’s disease-like neuropathology in rat striatum. Neuropathol Appl Neurobiol 25:513–521CrossRefPubMedGoogle Scholar
  65. Vis JC et al (2005) Expression pattern of apoptosis-related markers in Huntington’s disease. Acta Neuropathol 109:321–328CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Sarumani Natarajan Suganya
    • 1
  • Thangarajan Sumathi
    • 1
    Email author
  1. 1.Department of Medical Biochemistry, Dr. ALM Post Graduate Institute of Basic Medical SciencesUniversity of Madras, Taramani CampusChennaiIndia

Personalised recommendations